Health-Related Quality of Life in Patients Under Treatment With Apixaban in Latin America.

Atrial fibrillation (AF) has a strong impact on the quality of life (QOL) of patients and anticoagulation has a lot to do with it. We evaluated the QOL of patients with nonvalvular AF who start treatment with apixaban in Latin America. QOL was analyzed through a questionnaire developed to evaluate anticoagulated patients, which was completed by them 3 months after starting treatment.

Does high sensitivity troponin add prognostic value to validated risk scores to predict in-hospital mortality in patients with acute heart failure?

Troponin elevation correlates with an increased short and long-term mortality in patients with acute decompensated heart failure (AHF). However, it has not been included in the development of multiple validated predictive models of mortality. We aim to  determine whether the addition of high-sensitivity troponin T (hs-TnT) to clinical risk scores improves the prediction of in-hospital mortality in patients with AHF.

Impact of COVID-19 Pandemic Lockdown in Decompensated Heart Failure Hospitalizations.

Background And Objectives: Coronavirus disease 2019 (COVID-19) pandemic lockdown may have collaterally affected the care of patients with acute decompensated heart failure (ADHF). We aimed to evaluate the impact of lockdown pandemic on hospitalizations for ADHF.

Methods: We conducted a single-center study, performing a retrospective analysis of prospectively collected data.

Isochromosome 17q, a Rare Chromosomal Abnormality in a Female Patient with Pancytopenia.

Myelodysplastic syndromes present with a range of cytogenetic abnormalities that are used to guide diagnosis and management of the disease. Herein, we present the case of a 72-year-old female patient who presented with pancytopenia. Peripheral blood showed Hb 9.

Coexisting chordal papillary fibroelastoma and leaflet Lambl's tumour of the mitral valve.

Cardiac papillary fibroelastoma (CPF) is a rare and histologically benign tumour. It is the most common valvular tumour and the third cardiac benign tumour, after myxoma and lipoma (less then 16% of all cardiac tumours). CPF is a surgically correctable cause of cerebrovascular and myocardial infarction, making its identification by echocardiography beneficial.